Veterinary Anatomic Pathologist

Overview

Eli Lilly & Company is seeking a talented and energetic anatomic veterinary pathologist to work in drug discovery and development at the Lilly Corporate Center in Indianapolis, IN. The successful candidate will join a group of anatomic and clinical pathologists reporting to the Senior Director of Pathology in the Division of Toxicology and Pathology. They will provide scientific leadership in interpreting toxicity and pharmacologic effects caused by drugs, design, conduct, interpret, and peer review the pathology-related aspects of nonclinical studies, and represent pathology outcomes to global health authorities to support clinical trials and marketing authorizations.

Key expectations include identifying and resolving pathology and toxicology issues affecting the development of pharmaceuticals and frequent interaction with external business partners as a pathology peer reviewer.

Primary responsibilities include:

• Collaborate with cross-functional drug discovery teams and external partners to interpret toxicity and pharmacologic effects of drug candidates.
• Design, conduct, interpret, and peer review pathology components of nonclinical toxicity studies.
• Present pathology-related outcomes to global health authorities and support clinical trials and marketing authorizations.
• Identify and resolve pathology and toxicology issues affecting discovery and development of pharmaceuticals.
• Engage in cross-functional teams on drug discovery and development issues, and travel to partners and regulatory agencies as required.

Basic Qualifications:

• DVM or equivalent degree and certification by the American College of Veterinary Pathologists (ACVP) in Anatomic Pathology.
• Ph.D. in a related field of science.
• At least 2 years of experience evaluating, interpreting, and reporting GLP and non-GLP pathology data from nonclinical toxicity studies.
• Onsite presence in Indianapolis required.

• Experience in pathology peer review of GLP nonclinical toxicity data.
• Experience interpreting and reporting clinical pathology data from nonclinical toxicity studies.
• Experience evaluating and reporting pathology data from animal models of human disease or other drug discovery studies.
• Experience with digital pathology to evaluate and analyze pathology endpoints.
• Clear and concise oral and written communication skills, particularly of pathology data.
• Development of scientific and regulatory perspectives on emerging issues and excellent problem-solving skills.
• Ability to work individually or in cross-functional teams on drug discovery and development issues.
• Experience working with multiple therapeutic modalities.
• Readiness to travel to partners and regulatory agencies.

Actual compensation will depend on a candidate’s education, experience, skills, and geographic location. The anticipated wage for this position is $169,500 - $312,400. Full-time employees will also be eligible for company bonuses, a 401(k) plan, pension, vacation benefits, medical, dental, vision, prescription drug benefits, flexible spending accounts, life insurance, death benefits, leave of absence, and well-being benefits including employee assistance and fitness programs.

Lilly reserves the right to amend or modify compensation and benefits programs in its discretion.

Lilly is proud to be an EEO Employer and does not discriminate on the basis of age, race, color, religion, gender identity, sex, gender expression, sexual orientation, genetic information, ancestry, national origin, protected veteran status, disability, or any other legally protected status.